Pura Vida Investments’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

Pura Vida Investments’s Portfolio EFTRW Stock Details EFTRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-100,541	Closed	-$35K	–	288
2022 Q1	$35K	Hold	100,541	–	–	﹤0.01%	225
2021 Q4	$88K	Buy	+100,541	New	+$126K	﹤0.01%	229

Other funds holding EFTRW

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Evolution Capital Management Crystal Bay, Nevada $29M AUM 2.56% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

III Capital Management Boca Raton, Florida $344M AUM 11.22% 1-Year Est. Return

Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return

Pura Vida Investments's EFTRW Position: Q2 2022 in Review

Pura Vida Investments sold out of eFFECTOR Therapeutics, Inc. Warrant (EFTRW) in Q2 2022, closing a stake of 100,541 shares — an estimated $35K sold.

Pura Vida Investments first reported a position in EFTRW in Q4 2021 and held it in 2 quarters. The position peaked at $88K in Q4 2021. 16 funds tracked by Wall St. Rank hold EFTRW as of Q2 2022.

Pura Vida Investments reported no remaining eFFECTOR Therapeutics, Inc. Warrant position as of Q2 2022 after selling out during the quarter.
Pura Vida Investments sold 100,541 eFFECTOR Therapeutics, Inc. Warrant shares in Q2 2022, an estimated $35K.
Pura Vida Investments first reported a position in eFFECTOR Therapeutics, Inc. Warrant in Q4 2021 and held it in 2 quarters.
Pura Vida Investments's eFFECTOR Therapeutics, Inc. Warrant position peaked at $88K in Q4 2021.
16 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Warrant as of Q2 2022.

Based on Pura Vida Investments's 13F filing for Q2 2022, filed 15 Aug 2022.